Evidence map›Paper›PMID 17360460›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.

Hui Wu, Susan A Boackle, Punchong Hanvivadhanakul, Daniela Ulgiati, Jennifer M Grossman, Youngho Lee, Nan Shen, Lawrence J Abraham, Timothy R Mercer, Elly Park and 15 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 5 countries.

Hui WuDivision of Rheumatology, University of California-Los Angeles, 1000 Veteran Avenue, Los Angeles, CA 90095, USA.
Susan A Boackle
Punchong Hanvivadhanakul
Daniela Ulgiati
Jennifer M Grossman
Youngho Lee
Nan Shen
Lawrence J Abraham
Timothy R Mercer
Elly Park
Lee A Hebert
Brad H Rovin
Dan J Birmingham
Deh-Ming Chang
Chung Jen Chen
Deborah McCurdy
Humeira M Badsha
Bernard Y H Thong
Hiok H Chng
Frank C Arnett
Daniel J Wallace
C Yung Yu
Bevra H Hahn
Rita M Cantor
Betty P Tsao
University of California, Los Angeles · USThe Ohio State University · USTan Tock Seng Hospital · SGUniversity of Western Australia · AUCedars-Sinai Medical Center · USChang Gung University · TWHarry Perkins Institute of Medical Research · AURenji Hospital · CNThe University of Texas Health Science Center at Houston · USTri-Service General Hospital · TWUniversity of Colorado Denver · US

Funding

CHROMOSOME REGIONS LINKED TO SLE IN MULTIPLEX FAMILIESR01AR043814 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TSAO, BETTY P · 1997 to 2012
$5.7M
Functional Analysis of Complement Receptor 2 as a Lupus Susceptibility GeneR01AI070983 · NIAID · UNIVERSITY OF COLORADO DENVER · PI BOACKLE, SUSAN A. · 2006 to 2010
$2.4M
NIAID NIH HHS R01 AI070983NIAMS NIH HHS R01 AR043814NIAMS NIH HHS R01 AR 43814
6 · The paper itself

Abstract

A genomic region on distal mouse chromosome 1 and its syntenic human counterpart 1q23-42 show strong evidence of harboring lupus susceptibility genes. We found evidence of linkage at 1q32.2 in a targeted genome scan of 1q21-43 in 126 lupus multiplex families containing 151 affected sibpairs (nonparametric linkage score 2.52, P = 0.006). A positional candidate gene at 1q32.2, complement receptor 2 (CR2), is also a candidate in the murine Sle1c lupus susceptibility locus. To explore its role in human disease, we analyzed 1,416 individuals from 258 Caucasian and 142 Chinese lupus simplex families and demonstrated that a common three-single-nucleotide polymorphism CR2 haplotype (rs3813946, rs1048971, rs17615) was associated with lupus susceptibility (P = 0.00001) with a 1.54-fold increased risk for the development of disease. Single-nucleotide polymorphism 1 (rs3813946), located in the 5' untranslated region of the CR2 gene, altered transcriptional activity, suggesting a potential mechanism by which CR2 could contribute to the development of lupus. Our findings reveal that CR2 is a likely susceptibility gene for human lupus at 1q32.2, extending previous studies suggesting that CR2 participates in the pathogenesis of systemic lupus erythematosus.

Indexed as

HaplotypesAsian PeopleChinaFamily HealthFemaleGenetic LinkageGenetic Predisposition to DiseaseHumansLupus Erythematosus, SystemicMaleMicrosatellite RepeatsPolymorphism, Single NucleotideReceptors, Complement 3dRiskWhite PeopleReceptors, Complement 3d

Identifiers

PMID17360460
PMCPMC1820691
OpenAlexW1978017934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.